Moreover, MDM2 inhibitor (nutlin-3) delayed DNA repair of DSB in pancreatic ductal adenocarcinoma (PDAC model), suggesting that MDM2 inhibitors block MDM2 activities needed for effective DNA repair [46]. This evidence concerns the gene MDM2 and pancreatic ductal adenocarcinoma.